ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

GSK Gsk Plc

1,733.50
5.00 (0.29%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Gsk Plc GSK ロンドン Ordinary Share
  前日比 前日比 % 現在値 時刻
5.00 0.29% 1,733.50 00:35:18
始値 安値 高値 終値 前日終値
1,733.00 1,724.50 1,739.50 1,733.50 1,728.50
この銘柄の詳細情報 »
業種
PHARMACEUTICALS & BIOTECHNOLOGY

最新ニュース

日付 時間 ソース タイトル
2024/5/0323:30UK RNSGSK PLC Director/PDMR Shareholding
2024/5/0123:00UK RNSGSK PLC Total Voting Rights
2024/5/0116:50ALNCNewsTOP NEWS: GSK expects momentum to continue after strong..
2024/5/0115:00UK RNSGSK PLC 1st Quarter Results
2024/4/2417:14ALNCNewsGSK's Jemperli with chemotherapy accepted for priority..
2024/4/2415:00UK RNSGSK PLC US FDA accepts new indication filing for Jemperli
2024/4/1923:30UK RNSGSK PLC Director/PDMR Shareholding
2024/4/1723:30UK RNSGSK PLC Director/PDMR Shareholding
2024/4/1716:46ALNCNewsTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea..
2024/4/1715:05UK RNSGSK PLC GSK announces additional EAGLE-1 results
2024/4/1715:00UK RNSGSK PLC Results from long-term data relating to Shingrix
2024/4/1622:11UK RNSGSK PLC Amendment - Director/PDMR Shareholding
2024/4/1616:59ALNCNewsGSK's latest meningitis vaccine accepted for review by US..
2024/4/1615:00UK RNSGSK PLC FDA accepts GSK meningitis vaccine candidate file
2024/4/1523:30UK RNSGSK PLC Director/PDMR Shareholding
2024/4/0818:27ALNCNewsIN THE KNOW: Barclays ups GSK price target but HIV drug..
2024/4/0420:05UK RNSGSK PLC Replacement - Total Voting Rights
2024/4/0223:00UK RNSGSK PLC Total Voting Rights
2024/3/2700:30UK RNSGSK PLC Director/PDMR Shareholding
2024/3/2522:00UK RNSGSK PLC Notice of AGM
2024/3/2301:20UK RNSGSK PLC Transfer of Treasury Shares
2024/3/2300:36UK RNSGSK PLC Director/PDMR Shareholding
2024/3/1818:30UK RNSGSK PLC New Phase III Jemperli data in endometrial cancer
2024/3/1817:47ALNCNewsGSK says Jemperli combination gets good results for..
2024/3/1400:48UK RNSGSK PLC Director/PDMR Shareholding
2024/3/0902:12UK RNSGSK PLC Board Committee Change
2024/3/0718:38ALNCNewsGSK observes positive data in Blenrep trial for blood cancer..
2024/3/0716:00UK RNSGSK PLC GSK announces positive Blenrep DREAMM-8 results
2024/3/0701:00UK RNSGSK PLC ViiV LAI vs oral SOC data in adherence-challenged
2024/3/0602:24UK RNSGSK PLC GSK Annual Report 2023 on Form 20-F
2024/3/0520:03ALNCNewsGSK says ViiV's cabotegravir study supports longer HIV dose..
2024/3/0516:00UK RNSGSK PLC New ViiV LA formulation potential 4-month dosing
2024/3/0200:00UK RNSGSK PLC Total Voting Rights
2024/3/0121:15UK RNSGSK PLC GSK publishes Annual Report 2023
2024/2/2918:44ALNCNewsTOP NEWS: GSK avoids "protracted litigation" with Zantac..
2024/2/2916:05UK RNSGSK PLC Directorate Change
2024/2/2916:00UK RNSGSK PLC Statement: Zantac (ranitidine) litigation
2024/2/2700:30UK RNSGSK PLC Director/PDMR Shareholding
2024/2/2617:25ALNCNewsGSK gonorrhoea treatment achieves efficacy endpoint in..
2024/2/2616:00UK RNSGSK PLC GSK announces positive EAGLE-1 headline results
2024/2/2300:30UK RNSGSK PLC Director/PDMR Shareholding
2024/2/2118:47ALNCNewsGSK reports encouraging results for ViiV's Cabenuva HIV..
2024/2/2116:00UK RNSGSK PLC ViiV LAI superior to orals in adherence-challenged
2024/2/2018:01UK RNSGSK PLC Julie Brown - External Appointment
2024/2/2000:30UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1600:32UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1517:49ALNCNewsGSK completes USD1.4 billion purchase of respiratory firm..
2024/2/1516:00UK RNSGSK PLC GSK completes acquisition of Aiolos Bio
2024/2/1401:45UK RNSGSK PLC Director/PDMR Shareholding - Replacement
2024/2/1400:40UK RNSGSK PLC Director/PDMR Shareholding

最近閲覧した銘柄

Delayed Upgrade Clock